Viewing Study NCT05929495


Ignite Creation Date: 2025-12-24 @ 1:33 PM
Ignite Modification Date: 2026-01-26 @ 6:49 PM
Study NCT ID: NCT05929495
Status: RECRUITING
Last Update Posted: 2025-07-25
First Post: 2023-06-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma
Sponsor: University of Milano Bicocca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma, IDH-wildtype View
None Metformin View
None Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metformin View
None Gliomas View
None GBM View